A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Andy Yen-Tang Lee
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Andy Yen-Tang Lee
Assistant Health Sciences Professor, Medicine, School of Medicine
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)
- ID
- NCT05556512
- Phase
- Phase 3 Obesity Research Study
- Study Type
- Interventional
- Participants
- Expecting 15000 study participants
- Last Updated